• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

健康体检受检者发生肝细胞癌风险的预测:一项韩国队列研究。

Prediction of the risk of developing hepatocellular carcinoma in health screening examinees: a Korean cohort study.

机构信息

Department of Radiology, National Health Insurance Service Ilsan Hospital, Goyang, South Korea.

Research Institute, National Health Insurance Service Ilsan Hospital, Goyang, South Korea.

出版信息

BMC Cancer. 2021 Jun 29;21(1):755. doi: 10.1186/s12885-021-08498-w.

DOI:10.1186/s12885-021-08498-w
PMID:34187409
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8243543/
Abstract

BACKGROUND

Almost all Koreans are covered by mandatory national health insurance and are required to undergo health screening at least once every 2 years. We aimed to develop a machine learning model to predict the risk of developing hepatocellular carcinoma (HCC) based on the screening results and insurance claim data.

METHODS

The National Health Insurance Service-National Health Screening database was used for this study (NHIS-2020-2-146). Our study cohort consisted of 417,346 health screening examinees between 2004 and 2007 without cancer history, which was split into training and test cohorts by the examination date, before or after 2005. Robust predictors were selected using Cox proportional hazard regression with 1000 different bootstrapped datasets. Random forest and extreme gradient boosting algorithms were used to develop a prediction model for the 9-year risk of HCC development after screening. After optimizing a prediction model via cross validation in the training cohort, the model was validated in the test cohort.

RESULTS

Of the total examinees, 0.5% (1799/331,694) and 0.4% (390/85,652) in the training cohort and the test cohort were diagnosed with HCC, respectively. Of the selected predictors, older age, male sex, obesity, abnormal liver function tests, the family history of chronic liver disease, and underlying chronic liver disease, chronic hepatitis virus or human immunodeficiency virus infection, and diabetes mellitus were associated with increased risk, whereas higher income, elevated total cholesterol, and underlying dyslipidemia or schizophrenic/delusional disorders were associated with decreased risk of HCC development (p < 0.001). In the test, our model showed good discrimination and calibration. The C-index, AUC, and Brier skill score were 0.857, 0.873, and 0.078, respectively.

CONCLUSIONS

Machine learning-based model could be used to predict the risk of HCC development based on the health screening examination results and claim data.

摘要

背景

几乎所有韩国人都参加了强制性的国家医疗保险,并被要求每两年至少进行一次健康检查。我们旨在开发一种机器学习模型,根据筛查结果和保险索赔数据预测肝细胞癌(HCC)的发病风险。

方法

本研究使用了国家健康保险服务-国家健康筛查数据库(NHIS-2020-2-146)。我们的研究队列由 2004 年至 2007 年间无癌症史的 417346 名健康检查受检者组成,根据检查日期分为训练队列和测试队列,检查日期早于或晚于 2005 年。使用 Cox 比例风险回归和 1000 个不同的自举数据集选择稳健的预测因子。随机森林和极端梯度增强算法用于开发筛查后 9 年内 HCC 发展风险的预测模型。在训练队列中通过交叉验证优化预测模型后,在测试队列中对模型进行验证。

结果

在总受检者中,训练队列和测试队列中分别有 0.5%(1799/331694)和 0.4%(390/85652)被诊断为 HCC。在选定的预测因素中,年龄较大、男性、肥胖、肝功能异常、慢性肝病家族史、慢性肝病、慢性肝炎病毒或人类免疫缺陷病毒感染以及糖尿病与 HCC 发病风险增加相关,而较高的收入、总胆固醇升高以及潜在的血脂异常或精神分裂症/妄想障碍与 HCC 发病风险降低相关(p<0.001)。在测试中,我们的模型显示出良好的区分度和校准度。C 指数、AUC 和 Brier 技能评分分别为 0.857、0.873 和 0.078。

结论

基于健康检查结果和索赔数据,基于机器学习的模型可用于预测 HCC 发病风险。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a80f/8243543/839209ec229c/12885_2021_8498_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a80f/8243543/ed1abd563d79/12885_2021_8498_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a80f/8243543/2725916cc863/12885_2021_8498_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a80f/8243543/796ee6951902/12885_2021_8498_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a80f/8243543/dd13da0b0b1a/12885_2021_8498_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a80f/8243543/839209ec229c/12885_2021_8498_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a80f/8243543/ed1abd563d79/12885_2021_8498_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a80f/8243543/2725916cc863/12885_2021_8498_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a80f/8243543/796ee6951902/12885_2021_8498_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a80f/8243543/dd13da0b0b1a/12885_2021_8498_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a80f/8243543/839209ec229c/12885_2021_8498_Fig5_HTML.jpg

相似文献

1
Prediction of the risk of developing hepatocellular carcinoma in health screening examinees: a Korean cohort study.健康体检受检者发生肝细胞癌风险的预测:一项韩国队列研究。
BMC Cancer. 2021 Jun 29;21(1):755. doi: 10.1186/s12885-021-08498-w.
2
Development of a scoring system to predict hepatocellular carcinoma in Asians on antivirals for chronic hepatitis B.开发一种评分系统,以预测亚洲慢性乙型肝炎抗病毒治疗患者的肝细胞癌。
J Hepatol. 2018 Aug;69(2):278-285. doi: 10.1016/j.jhep.2018.02.032. Epub 2018 Mar 16.
3
Risk factors for hepatocellular carcinoma by age, sex, and liver disorder status: A prospective cohort study in Korea.按年龄、性别和肝脏疾病状况分层的肝细胞癌风险因素:韩国一项前瞻性队列研究。
Cancer. 2018 Jul 1;124(13):2748-2757. doi: 10.1002/cncr.31406. Epub 2018 Apr 18.
4
Effect of statin on hepatocellular carcinoma in patients with type 2 diabetes: A nationwide nested case-control study.他汀类药物对2型糖尿病患者肝细胞癌的影响:一项全国性巢式病例对照研究。
Int J Cancer. 2017 Feb 15;140(4):798-806. doi: 10.1002/ijc.30506. Epub 2016 Nov 16.
5
Association of fasting serum glucose level and type 2 diabetes with hepatocellular carcinoma in men with chronic hepatitis B infection: A large cohort study.空腹血糖水平及 2 型糖尿病与慢性乙型肝炎感染男性肝细胞癌的相关性:一项大型队列研究。
Eur J Cancer. 2018 Oct;102:103-113. doi: 10.1016/j.ejca.2018.07.008. Epub 2018 Sep 4.
6
Development of Risk Prediction Model for Hepatocellular Carcinoma Progression of Indeterminate Nodules in Hepatitis B Virus-Related Cirrhotic Liver.乙肝相关肝硬化肝脏中不确定结节肝细胞癌进展风险预测模型的开发
Am J Gastroenterol. 2017 Mar;112(3):460-470. doi: 10.1038/ajg.2016.480. Epub 2016 Oct 25.
7
Design and validation of risk prediction model for hepatocellular carcinoma development after sustained virological response in patients with chronic hepatitis C.慢性丙型肝炎患者持续病毒学应答后肝细胞癌发生风险预测模型的设计与验证
Eur J Gastroenterol Hepatol. 2020 Mar;32(3):378-385. doi: 10.1097/MEG.0000000000001512.
8
Assessment of a Deep Learning Model to Predict Hepatocellular Carcinoma in Patients With Hepatitis C Cirrhosis.评估深度学习模型在丙型肝炎肝硬化患者中预测肝细胞癌的价值。
JAMA Netw Open. 2020 Sep 1;3(9):e2015626. doi: 10.1001/jamanetworkopen.2020.15626.
9
Increased risk of hepatocellular carcinoma in chronic hepatitis C patients with new onset diabetes: a nation-wide cohort study.新发糖尿病的慢性丙型肝炎患者肝细胞癌风险增加:一项全国性队列研究
Aliment Pharmacol Ther. 2015 Oct;42(7):902-11. doi: 10.1111/apt.13341. Epub 2015 Jul 27.
10
Prediction of future hepatocellular carcinoma incidence in moderate to heavy alcohol drinkers with the FIB-4 liver fibrosis index.利用FIB-4肝纤维化指数预测中度至重度饮酒者未来肝细胞癌的发病率
Cancer. 2015 Nov 1;121(21):3818-25. doi: 10.1002/cncr.29577. Epub 2015 Jul 15.

引用本文的文献

1
Global, regional, and national burden of NASH related liver cancer in adults aged 45 and above: an analysis from the GBD 2021 and forecast to 2050.45岁及以上成年人中与非酒精性脂肪性肝炎相关的肝癌的全球、区域和国家负担:来自全球疾病负担研究(GBD)2021的分析及到2050年的预测
Front Nutr. 2025 Aug 19;12:1651357. doi: 10.3389/fnut.2025.1651357. eCollection 2025.
2
Comparison of models to predict incident chronic liver disease: a systematic review and external validation in Chinese adults.预测新发慢性肝病模型的比较:一项针对中国成年人的系统评价与外部验证
BMC Med. 2024 Dec 31;22(1):601. doi: 10.1186/s12916-024-03754-9.
3
Scoring System for Predicting the Risk of Liver Cancer among Diabetes Patients: A Random Survival Forest-Guided Approach.

本文引用的文献

1
Clinical and Molecular Prediction of Hepatocellular Carcinoma Risk.肝细胞癌风险的临床与分子预测
J Clin Med. 2020 Nov 26;9(12):3843. doi: 10.3390/jcm9123843.
2
Cardiovascular Research Using the Korean National Health Information Database.利用韩国国家健康信息数据库开展的心血管研究。
Korean Circ J. 2020 Sep;50(9):754-772. doi: 10.4070/kcj.2020.0171. Epub 2020 May 20.
3
Risk of hepatocellular carcinoma in individuals without traditional risk factors: development and validation of a novel risk score.无传统危险因素个体的肝细胞癌风险:新型风险评分的建立与验证。
糖尿病患者肝癌风险预测评分系统:一种随机生存森林引导的方法。
Cancers (Basel). 2024 Jun 24;16(13):2310. doi: 10.3390/cancers16132310.
4
Risk prediction of cholangitis after stent implantation based on machine learning.基于机器学习的支架植入术后胆管炎风险预测。
Sci Rep. 2024 Jun 14;14(1):13715. doi: 10.1038/s41598-024-64734-w.
5
Type 2 Diabetes Mellitus- and Complication-Related Risk of Nontuberculous Mycobacterial Disease in a South Korean Cohort.韩国队列中2型糖尿病及并发症相关的非结核分枝杆菌病风险
Microbiol Spectr. 2023 Mar 28;11(2):e0451122. doi: 10.1128/spectrum.04511-22.
6
The Impact of Artificial Intelligence on Health Equity in Oncology: Scoping Review.人工智能对肿瘤学中健康公平性的影响:范围综述。
J Med Internet Res. 2022 Nov 1;24(11):e39748. doi: 10.2196/39748.
Int J Epidemiol. 2020 Oct 1;49(5):1562-1571. doi: 10.1093/ije/dyaa089.
4
Introducing big data analysis using data from National Health Insurance Service.引入使用国民健康保险服务数据的大数据分析。
Korean J Anesthesiol. 2020 Jun;73(3):205-211. doi: 10.4097/kja.20129. Epub 2020 May 13.
5
Conducting and Reporting a Clinical Research Using Korean Healthcare Claims Database.利用韩国医疗保健理赔数据库开展和报告临床研究
Korean J Fam Med. 2020 May;41(3):146-152. doi: 10.4082/kjfm.20.0062. Epub 2020 May 20.
6
Statin Use is Protective Against Hepatocellular Carcinoma in Patients With Nonalcoholic Fatty Liver Disease: A Case-control Study.他汀类药物的使用可预防非酒精性脂肪性肝病患者的肝细胞癌:一项病例对照研究。
J Clin Gastroenterol. 2020 Sep;54(8):733-740. doi: 10.1097/MCG.0000000000001260.
7
A review of feature selection methods in medical applications.医学应用中的特征选择方法综述。
Comput Biol Med. 2019 Sep;112:103375. doi: 10.1016/j.compbiomed.2019.103375. Epub 2019 Jul 31.
8
Double-Edged Sword of Tumour Suppressor Genes in Schizophrenia.精神分裂症中肿瘤抑制基因的双刃剑效应
Front Mol Neurosci. 2019 Feb 12;12:1. doi: 10.3389/fnmol.2019.00001. eCollection 2019.
9
The trends in incidence of primary liver cancer caused by specific etiologies: Results from the Global Burden of Disease Study 2016 and implications for liver cancer prevention.特定病因引起的原发性肝癌发病率趋势:2016 年全球疾病负担研究结果及其对肝癌预防的意义。
J Hepatol. 2019 Apr;70(4):674-683. doi: 10.1016/j.jhep.2018.12.001. Epub 2018 Dec 11.
10
Development of a scoring system to predict hepatocellular carcinoma in Asians on antivirals for chronic hepatitis B.开发一种评分系统,以预测亚洲慢性乙型肝炎抗病毒治疗患者的肝细胞癌。
J Hepatol. 2018 Aug;69(2):278-285. doi: 10.1016/j.jhep.2018.02.032. Epub 2018 Mar 16.